The interaction between magnesium and other neuromuscular blocking agents.
D000818:Animals; D003650:Decamethonium Compounds / Q000494:pharmacology; D003964:Diaphragm / Q000187:drug effects; D004357:Drug Synergism; D005260:Female; D008274:Magnesium / Q000494:pharmacology*; D008297:Male; D009467:Neuromuscular Depolarizing Agents / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects*; D010791:Phrenic Nerve / Q000187:drug effects; D011247:Pregnancy; D051381:Rats; D013390:Succinylcholine / Q000494:pharmacology; D014403:Tubocurarine / Q000494:pharmacology
D003650:Decamethonium Compounds; D009467:Neuromuscular Depolarizing Agents; D008274:Magnesium; D013390:Succinylcholine; D014403:Tubocurarine